XS
TCRT icon

XR Securities’s Alaunos Therapeutics TCRT Stock Holding History

XR Securities’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-172
Closed -$2K – 580
2020
Q4 		$2K Hold
172
– – ﹤0.01% 420
2020
Q3 		$6K Sell
172
-4
-2% -$1.77K ﹤0.01% 265
2020
Q2 		$19K Hold
176
– – ﹤0.01% 209
2020
Q1 		$17K Buy
176
+8
+5% +$4.14K ﹤0.01% 176
2019
Q4 		$22K Sell
168
-1
-0.6% -$688 ﹤0.01% 195
2019
Q3 		$20K Buy
+169
New +$134K ﹤0.01% 191
2018
Q4 		– Sell
-82
Closed -$3K – 460
2018
Q3 		$3K Buy
+82
New +$35.2K ﹤0.01% 361

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return